ArticleLife (Basel, Switzerland)2025
Bioactive Compounds, Antibacterial, Antioxidant, Anticancer, and Antidiabetic Potential of the Seed and Leaves of
Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Natural Product-Based Therapeutic Potential ofPharmaceuticals (Basel, Switzerland) · 2026Article
- Phytochemical profile, antioxidant, antimicrobial activity, antibiofilm, cytotoxicity, and HR-LCMS of Tribulus terrestris.Journal, genetic engineering & biotechnology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
background
methodsGC-MS compared phytochemical profiles, and total phenolic and flavonoid content were determined. The extracts were tested for antibacterial activity (disc diffusion, MIC/MBC), antioxidant potential (DPPH, ABTS
resultsThe LE had a superior phytochemical composition, with greater phenolic and flavonoid levels. Compared to SE, it exhibited considerably higher antibacterial activity (MIC = 6.25-25 μg/mL), antioxidant potential (IC
conclusionsThe findings indicate the LE as a promising candidate for the development of standardized phytotherapeutically active compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.